A case of early thrombosis following a percutaneous tricuspid valve in valve implantation managed by thrombolysis.
Maryam ShojaeifardZahra RahnamounAta FirouziParham SadeghipourPublished in: Echocardiography (Mount Kisco, N.Y.) (2022)
Bioprosthetic valve thrombosis (BPVT) is a growing recognized entity, especially with the increasing use of the valve in vale procedures and the advent of new detection technologies (e.g., 4D CT and 4D echocardiography). The incidence of BPVT is higher in transcatheter valves than surgically implanted bioprosthetic valves. However, the best thromboprophylaxis regimen and optimal management strategy in the acute context remain unknown. This paper presents a case of early thrombosis following the percutaneous tricuspid valve in vale procedure that was successfully managed with thrombolysis.
Keyphrases
- aortic valve
- mitral valve
- pulmonary embolism
- aortic stenosis
- aortic valve replacement
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- left ventricular
- computed tomography
- ultrasound guided
- venous thromboembolism
- risk factors
- acute ischemic stroke
- pulmonary hypertension
- radiofrequency ablation
- magnetic resonance imaging
- coronary artery disease
- intensive care unit
- hepatitis b virus
- respiratory failure
- atrial fibrillation
- acute respiratory distress syndrome
- image quality
- drug induced
- extracorporeal membrane oxygenation